{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T21:25:08Z","timestamp":1772054708351,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP20ek0109458"],"award-info":[{"award-number":["JP20ek0109458"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10384-024-01100-3","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:05:15Z","timestamp":1722027915000},"page":"490-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1\/2, open label, single-arm trial"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-8133","authenticated-orcid":false,"given":"Mitsuru","family":"Arima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirosuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Misumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuka","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Imazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshiro","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuito","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Moritake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouichi","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Todaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Ieiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"1100_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstr\u00f6m","year":"2013","unstructured":"Hellstr\u00f6m A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382:1445\u201357.","journal-title":"Lancet"},{"issue":"suppl 1","key":"1100_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(suppl 1):35\u201349.","journal-title":"Pediatr Res"},{"key":"1100_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.ophtha.2016.03.026","volume":"123","author":"GE Quinn","year":"2016","unstructured":"Quinn GE, Barr C, Bremer D, Fellows R, Gong A, Hoffman R, et al. Changes in course of retinopathy of prematurity from 1986 to 2013: comparison of three studies in the United States. Ophthalmology. 2016;123:1595\u2013600.","journal-title":"Ophthalmology"},{"key":"1100_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2015.10244","volume":"314","author":"BJ Stoll","year":"2015","unstructured":"Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993\u20132012. JAMA. 2015;314:1039\u201351.","journal-title":"JAMA"},{"key":"1100_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1053\/j.semperi.2019.05.002","volume":"43","author":"C Gilbert","year":"2019","unstructured":"Gilbert C, Malik ANJ, Nahar N, Das SK, Visser L, Sitati S, et al. Epidemiology of ROP update \u2013 Africa is the new frontier. Semin Perinatol. 2019;43:317\u201322.","journal-title":"Semin Perinatol"},{"key":"1100_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3\u2009+\u2009retinopathy of prematurity. N Engl J Med. 2011;364:603\u201315.","journal-title":"N Engl J Med"},{"key":"1100_CR7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","volume":"394","author":"A Stahl","year":"2019","unstructured":"Stahl A, Lepore D, Fielder A, Fleck B, Reynolds JD, Chiang MF, et al. Ranibizumab versus laser therapy for the treatment of very low birth weight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet. 2019;394:1551\u20139.","journal-title":"Lancet"},{"key":"1100_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1001\/jama.2022.10564","volume":"328","author":"A Stahl","year":"2022","unstructured":"Stahl A, Sukgen EA, Wu WC, Lepore D, Nakanishi H, Mazela J, et al. Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity: the FIREFLEYE randomized clinical trial. JAMA. 2022;328:348\u201359.","journal-title":"JAMA"},{"key":"1100_CR9","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","volume":"132","author":"MM Geloneck","year":"2014","unstructured":"Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, et al. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol. 2014;132:1327\u201333.","journal-title":"JAMA Ophthalmol"},{"key":"1100_CR10","doi-asserted-by":"publisher","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","volume":"137","author":"J Morin","year":"2016","unstructured":"Morin J, Luu TM, Superstein R, Ospina LH, Lefebvre F, Simard MN, et al. Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics. 2016;137:e20153218.","journal-title":"Pediatrics"},{"key":"1100_CR11","doi-asserted-by":"publisher","first-page":"e0223972","DOI":"10.1371\/journal.pone.0223972","volume":"14","author":"YS Chang","year":"2019","unstructured":"Chang YS, Chen YT, Lai TT, Chou HC, Chen CY, Hsieh WS, et al. Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment. PLoS ONE. 2019;14:e0223972.","journal-title":"PLoS ONE"},{"key":"1100_CR12","doi-asserted-by":"publisher","first-page":"e0230678","DOI":"10.1371\/journal.pone.0230678","volume":"15","author":"M Arima","year":"2020","unstructured":"Arima M, Akiyama M, Fujiwara K, Mori Y, Inoue H, Seki E, et al. Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity. PLoS ONE. 2020;15:e0230678.","journal-title":"PLoS ONE"},{"key":"1100_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S2352-4642(21)00195-4","volume":"5","author":"N Marlow","year":"2021","unstructured":"Marlow N, Stahl A, Lepore D, Fielder A, Reynolds JD, Zhu Q, et al. 2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birth weight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial. Lancet Child Adolesc Health. 2021;5:698\u2013707.","journal-title":"Lancet Child Adolesc Health"},{"key":"1100_CR14","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.preteyeres.2021.101018","volume":"88","author":"AS Tsai","year":"2022","unstructured":"Tsai AS, Chou HD, Ling XC, Al-Khaled T, Valikodath N, Cole E, et al. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Prog Retin Eye Res. 2022;88:101018.","journal-title":"Prog Retin Eye Res"},{"key":"1100_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.oret.2018.08.002","volume":"3","author":"R Parikh","year":"2019","unstructured":"Parikh R, Pirakitikulr N, Chhablani J, Sakurada Y, Singh RP, Modi YS. A multinational comparison of anti-vascular endothelial growth factor use: the United States, the United Kingdom, and Asia-Pacific. Ophthalmol Retina. 2019;3:16\u201326.","journal-title":"Ophthalmol Retina"},{"key":"1100_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/APO.0000000000000313","volume":"9","author":"R Azad","year":"2020","unstructured":"Azad R, Gilbert C, Gangwe AB, Zhao P, Wu WC, Sarbajna P, et al. Retinopathy of prematurity: how to prevent the third epidemics in developing countries. Asia Pac J Ophthalmol (Phila). 2020;9:440\u20138.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"1100_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41433-019-0643-4","volume":"34","author":"P Sen","year":"2020","unstructured":"Sen P, Wu WC, Chandra P, Vinekar A, Manchegowda PT, Bhende P. Retinopathy of prematurity treatment: Asian perspectives. Eye (Lond). 2020;34:632\u201342.","journal-title":"Eye (Lond)"},{"key":"1100_CR18","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1167\/iovs.15-17411","volume":"57","author":"M Yamaguchi","year":"2016","unstructured":"Yamaguchi M, Nakao S, Arita R, Kaizu Y, Arima M, Zhou Y, et al. Vascular normalization by ROCK inhibitor: therapeutic potential of ripasudil (K-115) eye drop in retinal angiogenesis and hypoxia. Invest Ophthalmol Vis Sci. 2016;57:2264\u201376.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1100_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2337\/db19-1121","volume":"69","author":"M Arima","year":"2020","unstructured":"Arima M, Nakao S, Yamaguchi M, Feng H, Fujii Y, Shibata K, et al. Claudin-5 redistribution induced by inflammation leads to anti-VEGF-resistant diabetic macular edema. Diabetes. 2020;69:981\u201399.","journal-title":"Diabetes"},{"key":"1100_CR20","doi-asserted-by":"publisher","first-page":"e047003","DOI":"10.1136\/bmjopen-2020-047003","volume":"11","author":"M Arima","year":"2021","unstructured":"Arima M, Inoue H, Nakao S, Misumi A, Suzuki M, Matsushita I, et al. Study protocol for a multicentre, open-label, single-arm phase I\/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurity. BMJ Open. 2021;11:e047003.","journal-title":"BMJ Open"},{"key":"1100_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The International classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991\u20139.","journal-title":"Arch Ophthalmol"},{"key":"1100_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/00498254.2015.1096981","volume":"46","author":"T Isobe","year":"2016","unstructured":"Isobe T, Ohta M, Kaneko Y, Kawai H. Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase. Xenobiotica. 2016;46:579\u201390.","journal-title":"Xenobiotica"},{"key":"1100_CR23","doi-asserted-by":"publisher","first-page":"e697","DOI":"10.1097\/PR9.0000000000000697","volume":"4","author":"CM Campbell","year":"2019","unstructured":"Campbell CM, Gilron I, Doshi T, Raja S. Designing and conducting proof-of-concept chronic pain analgesic clinical trials. Pain Rep. 2019;4:e697.","journal-title":"Pain Rep"},{"key":"1100_CR24","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1200\/JCO.2005.01.149","volume":"23","author":"LV Rubinstein","year":"2005","unstructured":"Rubinstein LV, Korn EL, Freidlin B, Hunsberger S, Ivy SP, Smith MA. Design issues of randomized phase II trials and a proposal for phase II screening trials. J Clin Oncol. 2005;23:7199\u2013206.","journal-title":"J Clin Oncol"},{"key":"1100_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ejca.2014.10.027","volume":"51","author":"J Bogaerts","year":"2015","unstructured":"Bogaerts J, Sydes MR, Keat N, McConnell A, Benson A, Ho A, et al. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. Eur J Cancer. 2015;51:271\u201381.","journal-title":"Eur J Cancer"},{"key":"1100_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2307\/2530286","volume":"38","author":"R Brookmeyer","year":"1982","unstructured":"Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics. 1982;38:29\u201341.","journal-title":"Biometrics"},{"key":"1100_CR27","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1100_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2133\/dmpk.DMPK-11-NT-124","volume":"27","author":"Y Tayama","year":"2012","unstructured":"Tayama Y, Sugihara K, Sanoh S, Miyake K, Kitamura S, Ohta S. Developmental changes of aldehyde oxidase activity and protein expression in human liver cytosol. Drug Metab Pharmacokinet. 2012;27:543\u20137.","journal-title":"Drug Metab Pharmacokinet"},{"key":"1100_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10384-020-00754-z","volume":"64","author":"T Tachikawa","year":"2020","unstructured":"Tachikawa T, Ueno R, Mita T, Yuzurihara D, Katsumi O, Noda T, et al. Refractive state and visual acuity of children with extremely low birth weight at 3 years old in Japan. Jpn J Ophthalmol. 2020;64:539\u201348.","journal-title":"Jpn J Ophthalmol"},{"key":"1100_CR30","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1097\/IAE.0000000000003196","volume":"41","author":"C Iwahashi","year":"2021","unstructured":"Iwahashi C, Utamura S, Kuniyoshi K, Sugioka K, Konishi Y, Wada N, et al. Factors associated with reactivation after intravitreal bevacizumab or ranibizumab therapy in infants with retinopathy of prematurity. Retina. 2021;41:2261\u20138.","journal-title":"Retina"},{"key":"1100_CR31","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/IAE.0000000000002663","volume":"40","author":"KP Ling","year":"2020","unstructured":"Ling KP, Liao PJ, Wang NK, Chao AN, Chen KJ, Chen TL, et al. Rates and risk factors for recurrence of retinopathy of prematurity after laser or intravitreal anti-vascular endothelial growth factor monotherapy. Retina. 2020;40:1793\u2013803.","journal-title":"Retina"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01100-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01100-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01100-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T21:03:36Z","timestamp":1727125416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-024-01100-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1007\/s10384-024-01100-3","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"27 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. Arima, S. Nakao and KH. Sonoda have received funding and drug substance from Kowa Co., Ltd. to conduct non-clinical studies to confirm the efficacy of ripasudil prior to conducting this clinical trial. S. Nakao and Kowa Co., Ltd. have disclosed the patent WO 2014\/174747. No other potential conflicts of interest relevant to this article were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}